4.5 Review

Efficacy and Safety of Stem Cell Therapy in Children With Autism Spectrum Disorders: A Systematic Review and Meta-Analysis

Journal

FRONTIERS IN PEDIATRICS
Volume 10, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fped.2022.897398

Keywords

autism spectrum disorders (ASD); stem cell therapy; meta-analysis; efficacy; safety

Categories

Funding

  1. Foundation of Jiangxi Educational Committee [GJJ180791]
  2. Science and Technology Project of Jiangxi Provincial Health Commission [20191079]
  3. Open Project of Key Laboratory of Prevention and treatment of cardiovascular and cerebrovascular diseases, Ministry of Education [XN201913]
  4. Foundation of Technology Innovation Team of Gannan Medical University [TD201806]
  5. Key Project Foundation of Gannan Medical University [ZD201831]
  6. Gannan Medical University [QD076]
  7. Jiangxi Provincial Natural Science Foundation [20212BAB206075]

Ask authors/readers for more resources

The results of this meta-analysis suggest that stem cell therapy may be safe and effective for children with autism. However, the limited study size, lack of standardized injection routes and doses of stem cells, as well as shortages in diagnostic tools and long-term follow-up studies compromise the evidence. More studies are needed to systematically confirm the efficacy and safety of stem cell therapy for children with autism spectrum disorders.
Aim: There is insufficient evidence regarding the efficacy and safety of stem cell therapy for autism spectrum disorders. We performed the first meta-analysis of stem cell therapy for autism spectrum disorders in children to provide evidence for clinical rehabilitation. Methods: The data source includes PubMed/Medline, Web of Science, EMBASE, Cochrane Library and China Academic Journal, from inception to 24th JULY 2021. After sifting through the literature, the Cochrane tool was applied to assess the risk of bias. Finally, we extracted data from these studies and calculated pooled efficacy and safety. Results: 5 studies that met the inclusion criteria were included in current analysis. Meta-analysis was performed using rehabilitation therapy as the reference standard. Data showed that the Childhood Autism Rating Scale score of stem cell group was striking lower than the control group (WMD: -5.96; 95%CI [-8.87, -3.06]; p < 0.0001). The Clinical Global Impression score consolidated effect size RR = 1.01, 95%CI [0.87, 1.18], Z = 0.14 (p = 0.89), the effective rate for The Clinical Global Impression was 62% and 60% in the stem cell group and the control group, respectively. The occurrence events of adverse reactions in each group (RR = 1.55; 95%CI = 0.60 to 3.98; p = 0.36), there was no significant difference in the incidence of adverse reactions between the stem cell group and the control group. Conclusions: The results of this meta-analysis suggested that stem cell therapy for children with autism might be safe and effective. However, the evidence was compromised by the limitations in current study size, lacking standardized injection routes and doses of stem cells, as well as shortages in diagnostic tools and long period followup studies. Hence, it calls for more studies to systematically confirm the efficacy and safety of stem cell therapy for children with autism spectrum disorders.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available